Effects of Switching from Depakene to Generic Valproic Acid on Individuals with Mental Retardation

Comparison of brand-name Depakene with generic valproic acid medication to control seizures in 64 subjects with mental retardation living in an intermediate care facility found no statistically significant differences in seizures or blood levels. Results suggest use of the generic medication can res...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mental retardation (Washington) 1997-12, Vol.35 (6), p.468-471
Hauptverfasser:	Vadney, Victor J, Kraushaar, Kevin W
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anticonvulsants - therapeutic use Comparative Analysis Costs Cross-Over Studies Depakene Drug Therapy Drugs, Generic Humans Intellectual Disability - complications Mental Retardation Middle Aged Outcomes of Treatment Seizures Seizures - complications Seizures - drug therapy Valproic Acid Valproic Acid - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Comparison of brand-name Depakene with generic valproic acid medication to control seizures in 64 subjects with mental retardation living in an intermediate care facility found no statistically significant differences in seizures or blood levels. Results suggest use of the generic medication can result in substantial cost savings. (Author/DB)
ISSN:	0047-6765
DOI:	10.1352/0047-6765(1997)035<0468:EOSFDT>2.0.CO;2